A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil

NCT ID: NCT06675721

Last Updated: 2024-11-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-31

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to investigate vaccination acceptance and identify the reasons why people are not vaccinated.

People over 18 years of age who live in neighborhoods with socioeconomic vulnerability and with many cases of infectious diseases, as well as health professionals, will respond to a research questionnaire.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccine Hesitancy Vaccine Refusal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vulnerable group

Individuals who are over 18 years old and are residents of the socioeconomically vulnerable neighborhoods.

Study Questionnaire

Intervention Type OTHER

A survey questionnaire to assess factors related to vaccination adherence, including factors such as vaccine novelty, cost, and prior knowledge among vulnerable populations.

Health Professionals

Healthcare professionals who work in Natal.

Study Questionnaire

Intervention Type OTHER

A survey questionnaire to assess factors related to vaccination adherence, including factors such as vaccine novelty, cost, and prior knowledge among vulnerable populations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Study Questionnaire

A survey questionnaire to assess factors related to vaccination adherence, including factors such as vaccine novelty, cost, and prior knowledge among vulnerable populations.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals who are over 18 years old and are residents of the PAJUÇARA, FELIPE CAMARÃO, LAGOA AZUL, or PLANALTO neighborhoods, willing to answer the study questionnaire.
* Healthcare professionals who work in Natal, willing to answer the study questionnaire.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MSD Pharmaceuticals LLC

INDUSTRY

Sponsor Role collaborator

Centro De Estudos E Pesquisas Em Molestias Infecciosas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kleber G Luz, PhD

Role: PRINCIPAL_INVESTIGATOR

Centro De Estudos E Pesquisas Em Molestias Infecciosas

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kleber G Luz, PhD

Role: CONTACT

+55 84 999824374

Eveline P Milan, PhD

Role: CONTACT

+55 84 994027404

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EII1001HEVANO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Measles Vaccination at Health System Contacts
NCT04220671 ENROLLING_BY_INVITATION PHASE4
Measles Vaccine in HCW
NCT04357028 SUSPENDED PHASE3